1. Home
  2. ALKS vs LEU Comparison

ALKS vs LEU Comparison

Compare ALKS & LEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • LEU
  • Stock Information
  • Founded
  • ALKS 1987
  • LEU 1998
  • Country
  • ALKS Ireland
  • LEU United States
  • Employees
  • ALKS N/A
  • LEU N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • LEU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • ALKS Health Care
  • LEU Industrials
  • Exchange
  • ALKS Nasdaq
  • LEU Nasdaq
  • Market Cap
  • ALKS 5.1B
  • LEU 4.2B
  • IPO Year
  • ALKS 1991
  • LEU 1998
  • Fundamental
  • Price
  • ALKS $29.05
  • LEU $181.97
  • Analyst Decision
  • ALKS Strong Buy
  • LEU Buy
  • Analyst Count
  • ALKS 13
  • LEU 11
  • Target Price
  • ALKS $40.38
  • LEU $194.80
  • AVG Volume (30 Days)
  • ALKS 2.0M
  • LEU 1.6M
  • Earning Date
  • ALKS 07-29-2025
  • LEU 08-05-2025
  • Dividend Yield
  • ALKS N/A
  • LEU N/A
  • EPS Growth
  • ALKS 21.99
  • LEU 10.12
  • EPS
  • ALKS 2.08
  • LEU 6.16
  • Revenue
  • ALKS $1,505,296,000.00
  • LEU $436,900,000.00
  • Revenue This Year
  • ALKS N/A
  • LEU N/A
  • Revenue Next Year
  • ALKS $3.33
  • LEU $10.51
  • P/E Ratio
  • ALKS $13.99
  • LEU $29.80
  • Revenue Growth
  • ALKS N/A
  • LEU 12.72
  • 52 Week Low
  • ALKS $25.56
  • LEU $34.91
  • 52 Week High
  • ALKS $36.45
  • LEU $264.90
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 60.08
  • LEU 38.44
  • Support Level
  • ALKS $26.07
  • LEU $211.00
  • Resistance Level
  • ALKS $28.73
  • LEU $229.96
  • Average True Range (ATR)
  • ALKS 0.87
  • LEU 17.58
  • MACD
  • ALKS 0.35
  • LEU -7.07
  • Stochastic Oscillator
  • ALKS 97.94
  • LEU 5.55

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About LEU Centrus Energy Corp.

Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.

Share on Social Networks: